Skip to main content
Back to Investors

EISMEA Portfolio Companies

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

Last updated: July 2026

EISMEA Investment Overview

Portfolio Companies
609
Total Invested
$1.0B
Average Investment
$4.1M

EISMEA's Most Recent Investments (2020+)

Company NameFoundedFunding StageAmountCity
Hexagem2022Grant$2.3MLund
METAFORA biosystems2022Grant$2.6MÉvry
Yabie2022Series Unknown$16.0MStockholm
Cognibotics2022Series Unknown$6.0MLund
CardiacSense2022Series A$9.3MCaesarea
Lyfta2022Series Unknown$3.0MHelsinki
NEC OncoImmunity AS2022Seed$4.8MOslo
Deneb Medical2022Undisclosed$272KSan Sebastian
CH-Bioforce Oy2022Grant$16.5MEspoo
New Born Solutions2022Grant$2.8MBarcelona

Complete List of EISMEA Portfolio Companies (609)

Export
#CompanyStageAmountLocation
326HexagemGrant$2.3MLund, Sweden
327METAFORA biosystemsGrant$2.6MÉvry, France
328YabieSeries Unknown$16.0MStockholm, Sweden
329CogniboticsSeries Unknown$6.0MLund, Sweden
330CardiacSenseSeries A$9.3MCaesarea, Israel
331LyftaSeries Unknown$3.0MHelsinki, Finland
332NEC OncoImmunity ASSeed$4.8MOslo, Norway
333Deneb MedicalUndisclosed$272KSan Sebastian, Spain
334CH-Bioforce OyGrant$16.5MEspoo, Finland
335New Born SolutionsGrant$2.8MBarcelona, Spain
Nanotechnology

Hexagem develops dislocation-free GaN substrates for Power Electronics and relaxed InGaN platelets for µLED Displays

Lund, Sweden
June 2022
$2.3M
Grant

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedical

METAFORA biosystems is a biotechnology company developing the use of RBDs, innovative and unmatched ligands of nutrient transporters.

Évry, France
June 2022
$2.6M
Grant

Founder Contacts

19,000+ verified contacts

Enterprise SoftwareMobile AppsMobile PaymentsPaymentsPoint of SaleRetailRetail Technology

Yabie - One stop shop for in-store transactions and check-out. Fastest growing POS & Payment actor in Northern Europe

Stockholm, Sweden
June 2022
$16.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

Robotics

Cognibotics specializes in methods and services for high-performing and cost-effective determination of robot properties such as backlash.

Lund, Sweden
May 2022
$6.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyConsumer ElectronicsHealth CareHealth DiagnosticsMedical DevicemHealthWearables

CardiacSense is a developer of a wearable technology for continuous cardiac arrhythmia detection and non-inflating blood pressure monitoring

Caesarea, Israel
May 2022
$9.3M
Series A

Founder Contacts

19,000+ verified contacts

Augmented RealityDigital MediaEdTechEducationE-LearningTrainingVirtual Reality

Lyfta is a platform where teachers can find beautiful, engaging, and immersive content to capture the hearts and minds of their students.

Helsinki, Finland
April 2022
$3.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BioinformaticsBiotechnologyHealth CareMachine LearningMedical

NEC OncoImmunity AS is an artificial intelligence driven biotech company.

Oslo, Norway
April 2022
$4.8M
Seed

Founder Contacts

19,000+ verified contacts

HospitalityMedical Device

Deneb Medical is a start-up dedicated to developing a robotic platform.

San Sebastian, Spain
April 2022
$272K
Undisclosed

Founder Contacts

19,000+ verified contacts

BiotechnologyManufacturing

CH-Bioforce is the developer of the best biomass fractionation technology in the world.

Espoo, Finland
March 2022
$16.5M
Grant

Founder Contacts

19,000+ verified contacts

Health CareHealth DiagnosticsWellness

New Born Solutions is a medical device company that provides non-invasive screening for infant meningitis.

Barcelona, Spain
March 2022
$2.8M
Grant

Founder Contacts

19,000+ verified contacts

AutomotiveElectric VehicleManufacturing

K-Ryole is a privately held company that manufactures smart electric bike trailer.

Ivry-sur-seine, France
March 2022
$11.6M
Series B

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Enterprise SoftwareMarketing AutomationNatural Language ProcessingSaaS

Make smarter decisions for your paid campaigns with superhuman automated keyword management.

Madrid, Spain
February 2022
$395K
Seed

Founder Contacts

19,000+ verified contacts

Cynny business was acquired by Morphcast Inc. USA

Firenze, Italy
February 2022
$270K
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)Industrial AutomationRobotics

Denmark-based robotis company with a mission to bridge academic-based research to businesses. Focus is on commercializing robotics R&D.

Odense, Denmark
January 2022
$50.9M
Debt Financing

Founder Contacts

19,000+ verified contacts

Medical

Signia Therapeutics is an innovative French start-up company.

Lyon, France
January 2022
$1.9M
Grant

Founder Contacts

19,000+ verified contacts

B2BCommunitiesInformation TechnologyPaaSSoftware

Mesensei is a mobile platform as a service (PaaS) for high-value communities and ecosystems.

Helsinki, Finland
January 2022
$227K
Angel

Founder Contacts

19,000+ verified contacts

MedicalPharmaceuticalSoftware

MEDIKURA develops communication software for pharma companies

Munich, Germany
January 2022
$1.2M
Seed

Founder Contacts

19,000+ verified contacts

AgTechInformation TechnologyInsuranceInsurTechLogisticsShipping

Optimiz enables remote containerised cargo inspections and claims optimisation

London, United Kingdom
January 2022
$120K
Pre-Seed

Founder Contacts

19,000+ verified contacts

B2BIndustrial ManufacturingManufacturingSoftware

Prodsmart is real time process tracking for production lines and job shops. They turn any factory into a digital smart factory.

Lisboa, Portugal
December 2021
Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyGeneticsMedical

Depixus are pioneering the development of MAGNA, a novel genetic analysis technology for decoding the dynamic genome.

Paris, France
December 2021
$34.5M
Series A

Founder Contacts

19,000+ verified contacts

EnergyEnergy EfficiencyRenewable Energy

DHP Technology is a startup in the energy that aims to provide a contemporary energy supply that meets the requirements of the environment.

Zizers, Switzerland
December 2021
$1.7M
Equity Crowdfunding

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareNeuroscience

MaxWell Biosystems provides solutions to advance basic neuroscience research and accelerate preclinical drug discovery.

Basel, Switzerland
December 2021
Debt Financing

Founder Contacts

19,000+ verified contacts

Augmented RealityAutomotiveConsumer ElectronicsDigital SignageElectronicsHardwareRetail TechnologySoftwareSoftware EngineeringVirtual Reality

Ultraleap is working to create the most remarkable connection between people and technology.

Bristol, United Kingdom
November 2021
$80.9M
Series D

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceutical

Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.

Leiden, The Netherlands
November 2021
$60.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

AgricultureElectronicsFarmingInformation TechnologySoftware

Syrinjector LTD. is developing a full digital solution based on a novel portable automated syringe gun and software.

Gedera, Israel
November 2021
$2.3M
Series B

Founder Contacts

19,000+ verified contacts

Showing 326-350 of 609 portfolio companies

Frequently Asked Questions About EISMEA

How many companies has EISMEA invested in?

EISMEA has invested in 609 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does EISMEA invest in?

EISMEA's top investment sectors include Biotechnology, Health Care, Medical, Software, Artificial Intelligence (AI). The firm invests across 59 different industry categories.

What is EISMEA's largest investment?

Among tracked funding rounds, Ultraleap received $80.9M in a Series D round. EISMEA's total known invested capital is $1.0B.

What is the average investment size for EISMEA?

EISMEA's average investment size is $4.1M across its portfolio of 609 companies.

What are EISMEA's most recent investments?

Recent EISMEA portfolio additions include Hexagem, METAFORA biosystems, Yabie, Cognibotics, CardiacSense. These companies were founded in 2020 or later.

Explore Other Top Investors

Discover portfolio companies of other leading venture capital firms and investors.

View All Investors